Lumiracoxib, CAS 220991-20-8 Sole GMP Manufacturer
Lumiracoxib, CAS 220991-20-8 stable novel crystalline or amorphous form both we have, Lumiracoxib, CAS 220991-20-8no any IP problem. Lumiracoxib, CAS 220991-20-8 DMF filling, free sample of Lumiracoxib, CAS 220991-20-8.
EOS Med Chem have already carried out Lumiracoxib, CAS 220991-20-8 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Lumiracoxib, CAS 220991-20-8 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Lumiracoxib, CAS 220991-20-8 Intermeidates list, most from GMP plant:
Lumiracoxib, CAS 220991-20-8 HNMR, MASS, COA, MSDS we have.
Lumiracoxib, CAS 220991-20-8, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
Lumiracoxib, CAS 220991-20-8 stable novel crystalline or amorphous form both we have, Lumiracoxib, CAS 220991-20-8no any IP problem. Lumiracoxib, CAS 220991-20-8 DMF filling, free sample of Lumiracoxib, CAS 220991-20-8.
EOS Med Chem have already carried out Lumiracoxib, CAS 220991-20-8 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Lumiracoxib, CAS 220991-20-8 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Lumiracoxib, CAS 220991-20-8 Intermeidates list, most from GMP plant:
| Lumiracoxib, CAS 220991-20-8 Intermediate 52548-14-8, stock 8.2kg, assay 98.1%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 220991-50-4, stock 2.6kg, assay 98.8%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 1178576-91-4, stock 6.7kg, assay 98.5%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 220991-51-5, stock 6.6kg, assay 98.2%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 220991-52-6, stock 1.4kg, assay 98.3%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 1447730-92-8, stock 6.2kg, assay 98.7%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 220991-53-7, stock 8.2kg, assay 98.2%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 363-51-9, stock 1.9kg, assay 98.1%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 16634-82-5, stock 5.9kg, assay 98.6%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 2040-90-6, stock 6kg, assay 98.8%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 1175086-69-7, stock 8.1kg, assay 98.7%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 332903-74-9, stock 7.3kg, assay 98.2%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 332903-78-3, stock 5.5kg, assay 98.3%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 332903-83-0, stock 2.7kg, assay 98.4%, White powder. |
| Lumiracoxib, CAS 220991-20-8 Intermediate 1234562-75-4, stock 6.9kg, assay 98.1%, White powder. |
Lumiracoxib, CAS 220991-20-8 HNMR, MASS, COA, MSDS we have.
Lumiracoxib, CAS 220991-20-8, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
